Catalog Number EVO-22-27-12-D |
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 09/30/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
Additional information was requested, however no further information has been received to date.It was indicated that the device involved in this complaint was available to be returned for evaluation but to-date the device has not been received at cook (b)(4).As the device has not been received the cause of this complaint could not be conclusively determined.With the information provided a document based investigation was carried out.The customer complaint was confirmed based on customer testimony.Prior to distribution, all evo-22-27-12-d devices are subject to visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for the evo-22-27-12-d device of lot number c998632 revealed no discrepancies that could have contributed to this complaint issue.As per the instructions for use, notes section advises the user of the following: ¿if package is opened or damaged when received, do not use.Visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would inhibit proper working condition, do not use." from the information provided there were no adverse effects to the patient.Complaints of this nature will continue to be monitored for emerging trends.
|
|
Event Description
|
The first evo-22-27-12-d stent was placed successfully.Upon placing the second stent and removing the wire, the entire device came out with the wire; the stent never deployed.Possible break in the handle.Incident meets reporting criteria of an fda mdr report based on the reporting precedence for this device family for 'deployment issue resulting in exposed stent removed from patient with the delivery system' regardless of patient outcome.
|
|
Manufacturer Narrative
|
This correction follow up report is being submitted to cancel the initial report submitted relating to this event.Initial complaint description submitted as follows: the first (b)(4) stent was placed successfully.Upon placing the second stent and removing the wire, the entire device came out with the wire; the stent never deployed.Possible break in the handle.No adverse effects to the patient were reported to have occurred due to this incident.From the complaint information provided this incident initially met reporting criteria of an fda mdr report based on the reporting precedence for this device family for 'deployment issue resulting in exposed stent removed from patient with the delivery system' regardless of patient outcome.The device evaluation confirmed that the delivery system was returned for evaluation with no part of the stent exposed.The stent was fully retracted in the sheath.Based on the device evaluation this incident no longer meets the reporting criteria of an fda mdr report.Complaints of this nature will continue to be monitored for emerging trends.This correction follow up report is being submitted to cancel the initial report submitted relating to this event.Initial complaint description submitted as follows: the first (b)(4) stent was placed successfully.Upon placing the second stent and removing the wire, the entire device came out with the wire; the stent never deployed.Possible break in the handle.No adverse effects to the patient were reported to have occurred due to this incident.From the complaint information provided this incident initially met reporting criteria of an fda mdr report based on the reporting precedence for this device family for 'deployment issue resulting in exposed stent removed from patient with the delivery system' regardless of patient outcome.The device evaluation confirmed that the delivery system was returned for evaluation with no part of the stent exposed.The stent was fully retracted in the sheath.Based on the device evaluation this incident no longer meets the reporting criteria of an fda mdr report.Complaints of this nature will continue to be monitored for emerging trends.
|
|
Event Description
|
This correction follow up report is being submitted to cancel the initial report submitted relating to this event.Reference the additional mfg narrative-notes section for this justification.
|
|
Search Alerts/Recalls
|